Innovating Works
HORIZON-JU-IHI-2022-01-04
HORIZON-JU-IHI-2022-01-04: Access and integration of heterogeneous health data for improved healthcare in disease areas of high unmet public health need
Expected Impact:This topic aims to achieve the following:
Sólo fondo perdido 0 €
European
This call is closed Esta línea ya está cerrada por lo que no puedes aplicar.
An upcoming call for this aid is expected, the exact start date of call is not yet clear.
Presentation: Consortium Consortium: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Minimum number of participants.
This aid finances Proyectos:

Expected Impact:This topic aims to achieve the following:

Better and faster integration of future products, services and tools along the healthcare pathway, responding to patients’ specific needs and leading to improved health outcomes, patient safety and patient well-being.Wider availability of interoperable, large scale, quality data, respecting FAIR principles1 facilitating research and the development of integrated products and services.Advanced analytics/artificial intelligence (AI) supporting health research & innovation, resulting in:a) clinical decision support for increased accuracy of diagnosis and efficacy of treatment;b) wider availability of personalised health interventions to end-users;c) better evidence of the added value of new digital health and AI tools, including reduced risk of bias due to improved methodologies. 1 Wilkinson, M., Dumontier, M., Aalbersberg, I. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data 3, 160018 (2016). https://doi.org/10.1038/sdata.2016.18

Expected Outcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected o... see more

Expected Impact:This topic aims to achieve the following:

Better and faster integration of future products, services and tools along the healthcare pathway, responding to patients’ specific needs and leading to improved health outcomes, patient safety and patient well-being.Wider availability of interoperable, large scale, quality data, respecting FAIR principles1 facilitating research and the development of integrated products and services.Advanced analytics/artificial intelligence (AI) supporting health research & innovation, resulting in:a) clinical decision support for increased accuracy of diagnosis and efficacy of treatment;b) wider availability of personalised health interventions to end-users;c) better evidence of the added value of new digital health and AI tools, including reduced risk of bias due to improved methodologies. 1 Wilkinson, M., Dumontier, M., Aalbersberg, I. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data 3, 160018 (2016). https://doi.org/10.1038/sdata.2016.18

Expected Outcome:Proposals under this topic should aim to deliver results that contribute to all of the following expected outcomes for a specified disease area of high unmet public health need1:

Researchers, including industry stakeholders, have long-term access to diverse data at scale, enabled by the linkage and integration of novel and cross-sectoral sources, including industry sources. If possible, some of these data should be able to be used for providing evidence to support regulatory decision-making.Researchers, including industry stakeholders, have long-term access to new tools that enable the integration and analysis of these data. If possible, some of these tools should be able to be used for providing evidence to support regulatory decision-making.Citizens, including patients, are given user-friendly, interoperable tools to access their own health data from different sources to support disease self-management and empower joint health care professional - patient decision making.Health care professionals and healthcare providers2 have access to integrated data from diverse sources and clinical (and other) decision support systems to deliver better healthcare services to patients and populations in the most suitable and efficient manner. 1 Unmet public health needs are needs currently not addressed by healthcare systems for various reasons, for example if no medicines are known to treat a disease. Areas of public health importance are those where the burden of disease is high for patients and society due to the severity of the disease (in terms of mortality, physical and functional impairment, comorbidities, loss of quality of life…) and/or the number of people affected by it. For example, Alzheimer’s disease.

2 The term ’healthcare providers’ refers to organisations that deliver healthcare goods and services. Typical healthcare providers are hospitals, long-term care facilities, providers of ambulatory healthcare, laboratories, nursing care facilities, pharmacies and so on.

Scope:Over the past few years, there has been an explosion in the generation of data that could be harnessed for use in healthcare delivery and research. These data include data generated by digital technologies and patient reported outcome and experience measures, as well as data from clinical trials and routine clinical care. However, accessing, integrating & analysing these data to maximise the value for patient care and research is extremely challenging.

This topic aims to provide a scalable platform for the seamless integration or linkage of these diverse data at scale, and develop tools to allow the data to be used in clinical care, patient self-management and research in disease areas of high unmet public health.

For their proposed activities applicants should clearly identify a disease area of high unmet public health need1 taking into account comorbidities and/or functional status, and explain their choice with empirical evidence where possible.

Develop / further develop a scalable, open platform for the seamless integration or linkage of data at scale from diverse public and private data sources relevant to the disease area selected. These data sources should, as a minimum, include all of the following: clinical trials; registries; patient safety data; routine clinical care; publicly available health insurance data; patient reported outcome and experience measures; and data generated by digital technologies such as sensors, wearables and mHealth apps. Preferably, projects should also integrate data that has not usually been used before for the purpose of medical decision-making.Develop / further develop tools focused on the needs of patients, leveraging these diverse data sources to support patient self-management and empower joint healthcare professional - patient decision making.Develop / further develop clinical (and other) decision support systems leveraging these diverse data sources to allow clinicians to deliver better healthcare services to patients in the disease area selected.Demonstrate the added value of the platform and tools compared to current approaches through a use case (study) applied to the disease area selected.Demonstrate the widespread applicability and scalability of the platform & tools using data sources from outside of the projectPublish sufficient information, including access protocols, on the data that has been used in the project to facilitate long-term access and re-use, while ensuring compliance with the General Data Protection Regulation and other relevant European legislation. Applicants should also aim to deliver the following:

Public release of a set of minimum technical requirements for the developed platform/tools that includes interoperability, connectivity, data protection, cybersecurity and authentication/identification requirements that need to be met to allow the efficient integration of additional data from new devices/sensors/sources into the decision-support system after the project ends.Sustainable, ideally open-source tools that help ensure the quality and FAIRness[1] of data at source (e.g., automated tools to help data entry, semantic coding, and data management in particular in registries and databases maintained by healthcare professionals/providers and research institutions) as well as methodologies, quality standards and metrics to assess data quality.Sustainable tools to increase cross-border and cross-sector interoperability of health data from the diverse sources mentioned above. Ideally, these tools use open exchange formats and take into account relevant EU initiatives including the eHealth Digital Services Infrastructure (eHDSI)2 and the European Electronic Health Record Exchange Format (EEHRxF)3Sustainability plan/business model to ensure the long-term impact of the project results. Other considerations:

Applicants should build on clearly identified existing tools & platforms where possible, and ensure that the platform and tools developed can be applied to other disease areas or be relevant for other scientific and clinical communities (i.e. ensuring interoperability with other solutions). If applicants choose to develop a new data platform, a strong justification must be provided.Applicants must demonstrate that they have access to sufficient diverse data, including from industry sources, to meet the objectives of this topic. The data sources (name & country), types, and size must be described in the proposal alongside convincing evidence that the consortium will have access to these data for the project implementation.During their activities, applicants should ensure appropriate engagement of the end-users of the developed tools, especially patients and healthcare professionals.Applicants are expected to explore the integration of the outputs with the European Health Data Space (EHDS)4 when it becomes operational, and explore synergies with other relevant health data initiatives and projects. 1 Unmet public health needs are needs currently not addressed by healthcare systems for various reasons, for example if no medicines are known to treat a disease. Areas of public health importance are those where the burden of disease is high for patients and society due to the severity of the disease (in terms of mortality, physical and functional impairment, comorbidities, loss of quality of life…) and/or the number of people affected by it. For example, Alzheimer’s disease.

2 http://ec.europa.eu/health/ehealth-digital-health-and-care/electronic-cross-border-health-services_en

3 http://ec.europa.eu/digital-single-market/en/news/recommendation-european-electronic-health-record-exchange-format

4 http://ec.europa.eu/health/ehealth/dataspace_en

[1]

see less

Temáticas Obligatorias del proyecto: Temática principal: Health data Public health Electronic patient files

Consortium characteristics

Scope European : The aid is European, you can apply to this line any company that is part of the European Community.
Tipo y tamaño de organizaciones: The necessary consortium design for the processing of this aid needs:

characteristics of the Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Expected Impact:This topic aims to achieve the following: Expected Impact:This topic aims to achieve the following:
Do you want examples? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Financial Chapters: The chapters of financing expenses for this line are:
Personnel costs.
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Subcontracting costs.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
Purchase costs.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Other cost categories.
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Indirect costs.
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Madurez tecnológica: The processing of this aid requires a minimum technological level in the project of TRL 4:. Los componentes que integran determinado proyecto de innovación han sido identificados y se busca establecer si dichos componentes individuales cuentan con las capacidades para actuar de manera integrada, funcionando conjuntamente en un sistema. + info.
TRL esperado:

Characteristics of financing

Intensidad de la ayuda: Sólo fondo perdido + info
Lost Fund:
0% 25% 50% 75% 100%
For the eligible budget, the intensity of the aid in the form of a lost fund may reach as minimum a 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Guarantees:
does not require guarantees
No existen condiciones financieras para el beneficiario.

Additional information about the call

incentive effect: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
non -competitive competitive Very competitive
We do not know the total budget of the line
minimis: Esta línea de financiación NO considera una “ayuda de minimis”. You can consult the regulations here.

other advantages

SME seal: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
HORIZON-JU-IHI-2022-01-single-stage Access and integration of heterogeneous health data for improved healthcare in disease areas of high unmet public health need Expected Impact:This topic aims to achieve the following: Better and faster integration of future products, services and tools along the he...
Sin info.
HORIZON-JU-IHI-2022-03-05 Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences
en consorcio: ExpectedOutcome:R&I actions (projects) to be supported under this topic must contribute to all of the following outcomes: Robust eviden...
Cerrada does 2 years | next call scheduled for the month of
HORIZON-JU-IHI-2022-03-04 Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases
en consorcio: ExpectedOutcome:Research and innovation (R&I) actions to be supported under this topic must work towards results that contribute to all...
Cerrada does 2 years | next call scheduled for the month of
HORIZON-JU-IHI-2022-03-01 Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
en consorcio: ExpectedOutcome:R&I actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the foll...
Cerrada does 2 years | next call scheduled for the month of
HORIZON-JU-IHI-2022-03-03 Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
en consorcio: ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that con...
Cerrada does 2 years | next call scheduled for the month of
HORIZON-JU-IHI-2022-03-02 Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
en consorcio: ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that con...
Cerrada does 2 years | next call scheduled for the month of